Nisargandha M, Parwe S, Lade N, Padathpeedika Khalid J, Kuchewar V
Cureus. 2024; 16(4):e58294.
PMID: 38752052
PMC: 11094655.
DOI: 10.7759/cureus.58294.
Kumar A, Parkash O, Girdhar B
Biomed Res Int. 2014; 2014:283278.
PMID: 25101267
PMC: 4102069.
DOI: 10.1155/2014/283278.
Sengupta U
Indian J Clin Biochem. 2012; 12(Suppl 1):93-6.
PMID: 23100912
PMC: 3454309.
DOI: 10.1007/BF02873072.
Escobar-Gutierrez A, Amezcua M, Pasten S, Pallares F, Cazares J, Pulido R
J Clin Microbiol. 1993; 31(5):1329-33.
PMID: 8501238
PMC: 262930.
DOI: 10.1128/jcm.31.5.1329-1333.1993.
Kolk A, Ho M, Klatser P, Eggelte T, Kuijper S, de Jonge S
Clin Exp Immunol. 1984; 58(3):511-21.
PMID: 6439449
PMC: 1577099.
Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.
Bjune G, Closs O, Barnetson R
Clin Exp Immunol. 1983; 54(2):289-97.
PMID: 6228348
PMC: 1535902.
SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos.
Chakrabarty A, Maire M, Lambert P
Clin Exp Immunol. 1982; 49(3):523-31.
PMID: 6184189
PMC: 1536715.
Production and partial characterization of monoclonal antibodies to Mycobacterium leprae.
Gillis T, Buchanan T
Infect Immun. 1982; 37(1):172-8.
PMID: 6179876
PMC: 347507.
DOI: 10.1128/iai.37.1.172-178.1982.
Genetic epidemiology of the susceptibility to leprosy.
Shields E, Russell D, Pericak-Vance M
J Clin Invest. 1987; 79(4):1139-43.
PMID: 3549780
PMC: 424295.
DOI: 10.1172/JCI112930.
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies.
Britton W, Hellqvist L, Garsia R, Basten A
Clin Exp Immunol. 1987; 67(1):31-42.
PMID: 3304738
PMC: 1542553.
Leprosy.
Hastings R, Gillis T, Krahenbuhl J, Franzblau S
Clin Microbiol Rev. 1988; 1(3):330-48.
PMID: 3058299
PMC: 358054.
DOI: 10.1128/CMR.1.3.330.
Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens.
Lee S, Stoker N, Grant K, Handzel Z, Hussain R, McAdam K
Infect Immun. 1989; 57(8):2475-80.
PMID: 2663725
PMC: 313473.
DOI: 10.1128/iai.57.8.2475-2480.1989.
T-cell recognition of the 18-kilodalton antigen of Mycobacterium leprae.
Dockrell H, Stoker N, Lee S, Jackson M, Grant K, Jouy N
Infect Immun. 1989; 57(7):1979-83.
PMID: 2659530
PMC: 313830.
DOI: 10.1128/iai.57.7.1979-1983.1989.
Results of a World Health Organization-sponsored workshop on monoclonal antibodies to Mycobacterium leprae.
Infect Immun. 1985; 48(2):603-5.
PMID: 2580798
PMC: 261398.
DOI: 10.1128/iai.48.2.603-605.1985.
An ELISA-inhibition test using monoclonal antibody for the serology of leprosy.
Klatser P, de Wit M, Kolk A
Clin Exp Immunol. 1985; 62(3):468-73.
PMID: 2417764
PMC: 1577474.
Recombinant fusion protein identified by lepromatous sera mimics native Mycobacterium leprae in T-cell responses across the leprosy spectrum.
Laal S, Sharma Y, Prasad H, Murtaza A, Singh S, Tangri S
Proc Natl Acad Sci U S A. 1991; 88(3):1054-8.
PMID: 1992456
PMC: 50953.
DOI: 10.1073/pnas.88.3.1054.
Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.
Meyers W, Marty A
Drugs. 1991; 41(6):832-56.
PMID: 1715262
DOI: 10.2165/00003495-199141060-00003.
